Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) announced its earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.01), AnalystRatings.Net reports.

Cytosorbents Corp (NASDAQ:CTSO) opened at 0.29 on Wednesday. Cytosorbents Corp has a 52-week low of $0.08 and a 52-week high of $0.35. The stock’s 50-day moving average is $0.24 and its 200-day moving average is $0.24. The company’s market cap is $86.7 million.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.